ClariVest Asset Management’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

ClariVest Asset Management’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-17,667	Closed	-$630K	–	782
2023 Q1	$630K	Sell	17,667 -18	-0.1%	-$653	0.03%	354
2022 Q4	$649K	Sell	17,685 -68	-0.4%	-$2.69K	0.03%	350
2022 Q3	$838K	Sell	17,753 -5,590	-24%	-$361K	0.04%	286
2022 Q2	$1.67M	Sell	23,343 -6,000	-20%	-$439K	0.07%	212
2022 Q1	$2.38M	Hold	29,343	–	–	0.09%	194
2021 Q4	$3.01M	Sell	29,343 -15,400	-34%	-$1.48M	0.09%	199
2021 Q3	$3.91M	Sell	44,743 -2,600	-5%	-$235K	0.13%	165
2021 Q2	$4.24M	Sell	47,343 -24,700	-34%	-$2.09M	0.14%	148
2021 Q1	$5.46M	Sell	72,043 -23,467	-25%	-$1.77M	0.19%	100
2020 Q4	$6.51M	Sell	95,510 -31,785	-25%	-$1.98M	0.22%	82
2020 Q3	$6.76M	Sell	127,295 -15,535	-11%	-$925K	0.22%	84
2020 Q2	$8.32M	Sell	142,830 -7,459	-5%	-$401K	0.23%	85
2020 Q1	$5.92M	Sell	150,289 -19,480	-11%	-$1.14M	0.18%	97
2019 Q4	$10.1M	Sell	169,769 -49,987	-23%	-$2.69M	0.23%	90
2019 Q3	$11.7M	Buy	219,756 +18,817	+9%	+$966K	0.26%	92
2019 Q2	$10.3M	Buy	200,939 +26,398	+15%	+$1.23M	0.23%	102
2019 Q1	$9.04M	Buy	174,541 +127,098	+268%	+$6.16M	0.18%	124
2018 Q4	$1.87M	Sell	47,443 -700	-1%	-$32.5K	0.04%	322
2018 Q3	$2.48M	Hold	48,143	–	–	0.04%	293
2018 Q2	$2.26M	Sell	48,143 -8,300	-15%	-$344K	0.04%	327
2018 Q1	$2M	Sell	56,443 -157	-0.3%	-$6.15K	0.03%	340
2017 Q4	$2.47M	Buy	56,600 +17,613	+45%	+$823K	0.04%	314
2017 Q3	$2.04M	Hold	38,987	–	–	0.05%	284
2017 Q2	$2.28M	Buy	+38,987	New	+$2.03M	0.06%	269
2017 Q1	–	Sell	-78,246	Closed	-$4.12M	–	761
2016 Q4	$4.12M	Sell	78,246 -77	-0.1%	-$3.73K	0.11%	159
2016 Q3	$3.49M	Hold	78,323	–	–	0.1%	131
2016 Q2	$2.99M	Buy	78,323 +10,500	+15%	+$461K	0.09%	143
2016 Q1	$2.79M	Buy	67,823 +2,664	+4%	+$110K	0.08%	147
2015 Q4	$3.16M	Sell	65,159 -1,485	-2%	-$66.1K	0.09%	127
2015 Q3	$2.67M	Sell	66,644 -1,500	-2%	-$65.5K	0.08%	150
2015 Q2	$2.73M	Buy	+68,144	New	+$2.35M	0.08%	169

Other funds holding SYNH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

UOC

UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return

EIM

Elliott Investment Management West Palm Beach, Florida $20.1B AUM 60.76% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

GCL

Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

ClariVest Asset Management's SYNH Position: Q2 2023 in Review

ClariVest Asset Management sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2023, closing a stake of 17,667 shares — an estimated $630K sold.

ClariVest Asset Management first reported a position in SYNH in Q2 2015 and held it in 31 quarters. The position peaked at $11.7M in Q3 2019. 317 funds tracked by Wall St. Rank hold SYNH as of Q2 2023.

ClariVest Asset Management reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2023 after selling out during the quarter.
ClariVest Asset Management sold 17,667 Syneos Health, Inc. Class A Common Stock shares in Q2 2023, an estimated $630K.
ClariVest Asset Management first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2015 and held it in 31 quarters.
ClariVest Asset Management's Syneos Health, Inc. Class A Common Stock position peaked at $11.7M in Q3 2019.
317 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2023.

Based on ClariVest Asset Management's 13F filing for Q2 2023, filed 14 Aug 2023.